MolMed S.p.A.

02/26/2018 | Press release | Distributed by Public on 02/26/2018 06:16

MolMed and Miltenyi Biotec: EMA approves the utilization of the CliniMACS Prodigy® equipment in the commercial manufacturing process of Zalmoxis®, a patient-specific cell[...]